Home / BusinessBusinessMarketWatchBusinessMarketWatch·Aug 19, 2026·1 min readModerna’s stock doubles on promising cancer-vaccine resultsThe vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.View original source — MarketWatch ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessEuronewsBusinessAug 19, 2026 · 1 minUnitree's viral dancing, rollerblading robots make a 600% stock market debutEuronewsBusinessTASSBusinessAug 19, 2026 · 1 minPutin calls Russia’s economic growth modest but positiveTASSBusinessMarketWatchBusinessAug 19, 2026 · 1 minI’m leaving my grandkids money — but they must pass financial-literacy classes to get it. Is that fair?MarketWatchBusinessMarketWatchBusinessAug 19, 2026 · 1 minMarvell’s stock surges on news of Google chip deal — and Broadcom’s fallsMarketWatch
BusinessEuronewsBusinessAug 19, 2026 · 1 minUnitree's viral dancing, rollerblading robots make a 600% stock market debutEuronews
BusinessMarketWatchBusinessAug 19, 2026 · 1 minI’m leaving my grandkids money — but they must pass financial-literacy classes to get it. Is that fair?MarketWatch
BusinessMarketWatchBusinessAug 19, 2026 · 1 minMarvell’s stock surges on news of Google chip deal — and Broadcom’s fallsMarketWatch